2-Amino-1,1,1-trifluoro-3-(3'-indolyl)propane | 137496-38-9

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吲哚及其衍生物
• 英文名称: 2-Amino-1,1,1-trifluoro-3-(3'-indolyl)propane
• 英文别名: 2,2,2-trifluoro-1-(1H-indol-3-ylmethyl)ethylamine；1,1,1-trifluoro-3-(1H-indol-3-yl)propan-2-amine
• CAS: 137496-38-9
• 化学式: C₁₁H₁₁F₃N₂
• 分子量: 228.217
• InChiKey: KDECNUFSXVWZKT-UHFFFAOYSA-N

物化性质

• 沸点：
  359.3±42.0 °C(Predicted)
• 密度：
  1.329±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.7
• 重原子数：
  16
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.27
• 拓扑面积：
  41.8
• 氢给体数：
  2
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  2-Amino-1,1,1-trifluoro-3-(3'-indolyl)propane 在 4-二甲氨基吡啶 、 copper(l) iodide 、 1,10-菲罗啉 、 18-冠醚-6 、 caesium carbonate 、 溶剂黄146 、 三乙胺 、 N,N-二异丙基乙胺 作用下， 以 四氢呋喃 、 1,4-二氧六环 、 甲苯 为溶剂， 反应 60.0h， 生成 2-[3,5-Difluoro-4-[2-(2-fluoro-2-methylpropyl)-3-(trifluoromethyl)-1,3,4,9-tetrahydropyrido[3,4-b]indol-1-yl]phenoxy]ethyl 4-methylbenzenesulfonate
  参考文献：
  名称：

  [EN] SELECTIVE ESTROGEN RECEPTOR DEGRADERS AND USES THEREOF
  [FR] AGENTS DE DÉGRADATION SÉLECTIFS DES RÉCEPTEURS DES ŒSTROGÈNES ET LEURS UTILISATIONS

  摘要：

  本公开提供了Formula (I)和Formula (II)的化合物。本文描述的化合物可能在治疗增殖性疾病（例如癌症）方面有用。本公开还提供了包括或使用本文描述的化合物的药物组合物、试剂盒、方法和用途。

  公开号：

  WO2017136688A1
• 作为产物：
  描述：

  1,1,1-Trifluoro-3-(indol-3-yl)propan-2-one 2-oxime 在 lithium aluminium tetrahydride 作用下， 以 乙醚 为溶剂， 反应 24.0h， 以41%的产率得到2-Amino-1,1,1-trifluoro-3-(3'-indolyl)propane
  参考文献：
  名称：

  Efficient synthesis of trifluoromethyl-substituted 5,6-dihydro-4H-1,2-oxazines by the hetero-Diels-Alder reaction of 1,1,1-trifluoro-2-nitroso-2-propene and electron-rich olefins

  摘要：

  1,1,1-Trifluoro-2-nitroso-2-propene (1) was generated in situ by treatment of the alpha-bromo oxime 5 with base. Moderate to excellent yields of the 3-trifluoromethyl-substituted 1,2-oxazines 17-27 were obtained from the reaction of 1 and the silyl enol ethers 6-16, respectively. Other dienophiles, i.e., allyltrimethylsilane, cyclopentadiene, furan, and dihydropyran, upon reaction with 1 provided the cycloadducts 31-34, respectively, in good yield. The results demonstrated that 1 is probably the most reactive heterodiene that has so far been employed in this type of Diels-Alder reaction (i.e., Diels-Alder reaction with inverse electron demand). The mechanism of the reaction and diastereoselectivity of the cycloadditions are discussed. The reaction of 1 with indole and acetyl acetone afforded the oxime 38 and a mixture of the isomers 40-42, respectively. Also, ring openings and other transformations of the trifluoromethyl-substituted 1,2-oxazines were effected. Acid-induced desilylation of the silylated 1,2-oxazines provided oximes like 46 and 48 or 6-hydroxy-1,2-oxazines like 47. Treatment of the 1,2-oxazines with Mo(CO)6 in the presence of trifluoroacetic acid produced 2-trifluoromethyl-substituted pyrroles (e.g., 18 --> 50). The reduction of the 1,2-oxazines afforded either gamma-hydroxy oximes (e.g., 19 --> 51) or amino alcohols (e.g., 32 --> 52, 31 --> 55). The reduction of the indole derivative 38 by LiAlH4 provided the trifluoromethyl-substituted tryptamine 56. The results of these explorative studies demonstrated that readily available trifluoromethyl-substituted 1,2-oxazines could be efficiently converted into other compounds that bear a trifluoromethyl group.

  DOI：

  10.1021/jo00027a058

文献信息

• Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
  申请人：Kuzmich Daniel

  公开号：US20060154925A1

  公开（公告）日：2006-07-13

  Compounds of Formula (I) wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , and R 7 are as defined herein, or a tautomer, prodrug, solvate, or salt thereof; pharmaceutical compositions containing such compounds, and methods of modulating the glucocorticoid receptor function and methods of treating disease-states or conditions mediated by the glucocorticoid receptor function or characterized by inflammatory, allergic, or proliferative processes in a patient using these compounds.

  式（I）的化合物 其中R1，R2，R3，R4，R5，R6和R7如本文所定义，或其互变异构体，前药，溶剂合物或盐；含有这些化合物的药物组合物，以及使用这些化合物调节糖皮质激素受体功能的方法，以及使用这些化合物治疗由糖皮质激素受体功能介导或以炎症，过敏或增殖过程为特征的疾病状态或病况的方法。
• Biocatalysts and methods for synthesizing derivatives of tryptamine and tryptamine analogs
  申请人：Codexis, Inc.

  公开号：US10544402B2

  公开（公告）日：2020-01-28

  The present disclosure provides engineered transaminase polypeptides for the production of amines, polynucleotides encoding the engineered transaminases, host cells capable of expressing the engineered transaminases, and methods of using the engineered transaminases to prepare compounds useful in the production of active pharmaceutical agents.

  本公开提供了用于生产胺的工程化转氨酶多肽、编码工程化转氨酶的多核苷酸、能够表达工程化转氨酶的宿主细胞，以及使用工程化转氨酶制备用于生产活性药剂的化合物的方法。
• Selective estrogen receptor degraders and uses thereof
  申请人：INVENTISBIO INC.

  公开号：US10647724B2

  公开（公告）日：2020-05-12

  The present disclosure provides compounds of Formula (I) and Formula (II). The compounds described herein may be useful in treating proliferative diseases (e.g., cancer). Also provided in the present disclosure are pharmaceutical compositions, kits, methods, and uses including or using a compound described herein.

  本公开提供了式 (I) 和式 (II) 的化合物。本文所述化合物可用于治疗增殖性疾病（如癌症）。本公开还提供了包括或使用本文所述化合物的药物组合物、试剂盒、方法和用途。
• GLUCOCORTICOID MIMETICS, METHODS OF MAKING THEM, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF
  申请人：Boehringer Ingelheim Pharmaceuticals Inc.

  公开号：EP1836166A2

  公开（公告）日：2007-09-26
• BIOCATALYSTS AND METHODS FOR SYNTHESIZING DERIVATIVES OF TRYPTAMINE AND TRYPTAMINE ANALOGS
  申请人：Codexis, Inc.

  公开号：EP2828385B1

  公开（公告）日：2018-02-07